Alexander Lepioshkin

Часть публикаций из профиля, по году от новых к старым. Это не полный список последних работ автора; работы без года — в конце.

• Enhanced Antiviral Activity of Novel Umifenovir Derivatives against SARS-CoV-2: Insights from an International Collaborative Study2026
• Enhanced Antiviral Activity of Novel Umifenovir Derivatives against SARS-CoV-2: Insights from an International Collaborative Study2026
• Targeting virulence in Mycobacterium tuberculosis and nontuberculous mycobacteria: Focus on anti-infective drug design2025
• Efficacy of dispirotripiperazine PDSTP in a golden Syrian hamster model of SARS-CoV-2 infection2025
• Antidepressant-like Effect of the Eburnamine-Type Molecule Vindeburnol in Rat and Mouse Models of Ultrasound-Induced Depression2024
• Machine Learning Models for Mycobacterium tuberculosis In Vitro Activity: Prediction and Target Visualization2021 · аннотациясвернуть

  Tuberculosis (TB) is a major global health challenge, with approximately 1.4 million deaths per year. There is still a need to develop novel treatments for patients infected with Mycobacterium tuberculosis ( Mtb ).…

• Design and Synthesis of Pyrano[3,2- b ]indolones Showing Antimycobacterial Activity2020
• PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection2019 · аннотациясвернуть

  C109 is a potent but poorly soluble FtsZ inhibitor displaying promising activity against Burkholderia cenocepacia, a high-risk pathogen for cystic fibrosis (CF) sufferers. To harness C109 for inhalation, we developed…